Eve received FDA clearance for a device and is targeting the US healthcare market and Medicare reimbursement.

The entities involved

• Eve →

  Beauty, cosmetic and personal care company

  Nothing else this week.

• Medicare →

  US federal health insurance

  • Chris Hooper, a resident of Castlemaine, questioned the differences between private health cover and Medicare.22:09
  • A commentary piece links Trump's coin minting, the Marshall Plan, and Medicare adoption to reflect American values.18:11
• FDA →
  • NRx Pharmaceuticals is undergoing a first-cycle review of an ANDA for ketamine, noting its strategic importance for the U.S. military and VA.19:54
  • BridgeBio announced on August 14, 2026, that it has submitted New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA).17:22

Related events

• FDA issued an Early Alert regarding a device issue involving Edwards Lifesciences.Oct 17
• Vivos is advancing its product line by securing patents via USPTO filings and gaining unprecedented 510K clearances for an alternative to CPAP technology.Aug 5
• FDA policy proposal affects the operations of AI, Inc.Oct 16
• UnitedHealthcare offers Medicare Rx plans while CMS provides 2027 plan files for projections.Sat 16:07
• FDA confirmed CMC and device plans are Phase 3 ready, coinciding with strengthening of US and EU patent estates.Aug 6